FdaApplication
ANDA 210317
Identifiers
- fda_app_no: ANDA210317
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2023-12-05 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | EQ 10MG BASE/VIAL | INJECTABLE;INJECTION |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | EQ 30MG BASE/VIAL | INJECTABLE;INJECTION |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | EQ 20MG BASE/VIAL | INJECTABLE;INJECTION |
3 products